The DEA’s proposal would classify concentrated synthetic 7-OH products as Schedule I drugs, while leaving most botanical kratom outside the ban.
As reported in our April 11, 2025, blog item, applications for currently unavoidable use determinations for products containing intentionally added perfluoroalkyl and polyfluoroalkyl substances (PFAS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results